Liminatus Pharma, Inc. · NASDAQ:LIMN

Iris Acquisition Holdings LLC reported a 26.50% stake in Liminatus Pharma, Inc. (Schedule 13D)

Event Apr 30, 2025 · Filed May 8, 2025

Iris Acquisition Holdings LLC reported a 26.50% stake in Liminatus Pharma, Inc., 6,900,000 shares, with active intent on Apr 30, 2025. Filed May 8, 2025 (Schedule 13D).

Stake
26.50%
Shares
6,900,000
Intent
Active
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Iris Acquisition Holdings LLC26.50%6,900,000

Source

View original at SEC

Related